9th Sep 2015 06:54
LONDON (Alliance News) - Horizon Discovery Group PLC said Wednesday that it has entered into a licence and supply agreement with Abcam PLC, under which it will get GBP660,000 in exclusivity payments across an initial three-year term.
If Abcam opts to extend the exclusive period under the agreement, a further GBP1.28 million in payments could be paid for a further three years.
Under the agreement Abcam will get exclusive access to over 1,800 human diploid and haploid cell line models from Horizon's X-MAN collection. Horizon will also develop additional haploid cell lines to validate new antibodies introduced by Abcam, it said.
"This agreement represents significant progress for Horizon in creating new and scalable channels to market for its cell line products. Abcam's choice of Horizon's cell lines to support the development and quality control for their antibody catalog further validates the value that our cell lines can provide in a variety of applications," said Horizon Discovery's President of Products Paul Morrill in a statement.
"We believe that this agreement represents the first step in building a long term relationship with a true world-leader in the research antibody field," Morrill added.
By Hana Stewart-Smith; [email protected]; @HanaSSAllNews
Copyright 2015 Alliance News Limited. All Rights Reserved.
Related Shares:
ABC.LHZD.L